Teladoc Inc Stock News

Teladoc's stock fell ~97% from its peak, but recent changes, including a new CEO, present a high-risk, high-reward opportunity. Positive year-over-year trends in integrated care members and chronic care enrollment, but effective monetization of these members remains a challenge. However, Teladoc's strong FCF and cheap valuation, trading at 4-5 times FCF, make it a potential turnaround candidate.

PURCHASE, NY, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that it issued an inducement award to a new employee.

Teladoc Health boasts substantial strengths and is positioned for enhanced performance, but according to new CEO Chuck Divita, there is work to do.

Teladoc's second-quarter financial results disappointed investors. The telemedicine company still has several things going its way.

Teladoc's new management has delivered a painful FQ2'24 earnings call, as observed in the BetterHelp impairment costs and withdrawn forward guidance. It is apparent that the telehealth company is facing growth issues and elevated marketing/advertising costs, with its near-term prospects likely to remain underwhelming. Readers must note the upcoming Livongo notes are likely to trigger further eq...

In general, I'm quite bullish on the healthcare sector. Many of the names in the space have extremely low valuations because a high percentage of investors irrationally believed that healthcare companies could never perform well when interest rates were high.

Revenue of $642.4 million was within management's guidance range. Adjusted EBITDA significantly exceeded expectations at $89.5 million.

Teladoc Health, Inc. stock has plummeted >95% since its peak in early 2021, with the downtrend near constant. Losses are usually exacerbated by quarterly earnings, and Q2 earnings, announced yesterday, were no exception. Teladoc's new CEO withdrew all guidance for 2024, signaling potential challenges ahead, especially with the BetterHelp segment facing high customer acquisition costs and churn.